Made Scientific has rebuilt Resolution Therapeutics' GMP suite layouts as fully interactive, to-scale 3D models — and sequenced the infrastructure ahead of need, from tech transfer through commercial supply and future expansion.
See the phased plan ↓Made Scientific's infrastructure is sequenced ahead of Resolution's program — with preferred paths and ready-allocated contingencies at every phase, from tech transfer through commercial supply.
| # | Phase | Preferred Location | Contingency |
|---|---|---|---|
| 1 | Technology Transfer | 201 Development FacilityReady and allocated | — |
| 2 | GMP Pilot Runs (3×) | 201 Suites 1–4Ready and allocated | — |
| 3 | GMP Engineering Runs (3×) | 201 Expansion (Suites 6, 7, or 8)Preferred, ready ahead of need | 201 Suites 1–4Ready |
| 4 | Pivotal Trial – Commercial Y2 Manufacturing | 201 Expansion (Suites 6, 7, or 8)Preferred, ready ahead of need, up to 25 starts/week | 201 Suites 1–4Ready, max 2 starts/week per suite |
| 5 | Y3+ Commercial Manufacturing | 307 ExpansionPreferred, custom-designed for Resolution, ready ahead of need | 201 Expansion (6, 7 or 8)Ready ahead of need |
Each card opens a live, to-scale 3D model — drag to orbit, scroll to zoom, and toggle people, labels and equipment.
The validated single-suite clinical manufacturing configuration.
Pivotal-to-commercial GMP suite (Princeton 201 — primary).
Ground-up open-ballroom site with harvest & Grade B rooms.
A ground-up campus expansion — Princeton 307, custom-designed for Resolution to carry the program from pivotal supply through full commercial scale.
Ground-up campus expansion, custom-designed for Resolution — up to 8 commercial ballrooms (1,250–1,500 SF each), built to fit.
Provisioned to demand — Prodigy · Incubator · Rotea · Nucleofector · Cue, scaled to patient enrollment.